[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hospital Arnau de Vilanova\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":102},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100632870","effectiveness-of-a-needle-free-connector-with-anti-reflux-technology-in-reducing-complications-from-long-peripheral-venous-catheters-in-hospitalised-adult-patients-randomised-clinical-trial-100632870",false,"NCT07519304","Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Venous Catheters in Hospitalised Adult Patients: Randomised Clinical Trial","FLUSH-ETI","Inclusion Criteria:\n\n* Patients requiring placement of a long peripheral venous catheter.\n* Patients who have provided written informed consent.\n* Patients with an expected hospital stay of ≥7 days.\n\nExclusion Criteria:\n\n\\- Inability to place a long peripheral venous catheter in the upper limbs.","ALL",{"count":18,"type":19},62,"ESTIMATED","INTERVENTIONAL",[22],"NA","A study to evaluate a needle-free connector (a stopper) featuring anti-reflux technology (to prevent blood from flowing back) for catheters (polyurethane tubes inserted into a vein), with the aim of reducing complications associated with these devices: blockages, infections, pain, etc.",[25,26,27,28,29],"Vascular Access Devices","Catheters","Occlusion","Thrombosis","Randomised Controlled Trial",[31],"Needleless connector","NOT_YET_RECRUITING","2026-04-15",{"date":35,"type":36},"2026-04-16","ACTUAL",{"date":38,"type":19},"2026-04-20",{"date":40,"type":19},"2026-12-31",{"name":42,"class":43},"Hospital Arnau de Vilanova","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":20,"phases":55,"briefSummary":56,"conditions":57,"keywords":62,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":73,"locationsCount":74},"100575291","effectiveness-of-a-zinc-oxide-adhesive-securement-device-in-the-fixation-of-midline-and-peripherally-inserted-central-catheters-in-hospitalized-adult-patients-100575291","NCT06770374","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial","FIX-ETI","Inclusion Criteria:\n\n* requiring cannulation of a midline catheter or a PICC\n* who accepted and signed the informed consent voluntarily\n* with an inpatient unit admission of minimum 7 days\n\nExclusion Criteria:\n\n\\- patients with a known allergy to zinc oxide","18 Years",{"count":54,"type":19},400,[22],"Study in which a zinc oxide fixation device (a product that can help protect the skin) for catheters (polyurethane tubes inserted into a vein) will be tested to reduce catheter-related complications: catheter displacement, skin complications, phlebitis and pain..",[58,59,60,61],"Vascular Access Complication","Skin and Subcutaneous Tissue Disorders","Phlebitis","Pain",[26,25,63,64,65,29],"Catheter-Related Infections","Nurse Specialists","Nurses","RECRUITING","2026-04-02",{"date":69,"type":36},"2026-04-08",{"date":71,"type":36},"2025-02-01",{"date":40,"type":19},{"name":42,"class":43},2,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":20,"phases":84,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},"100552666","optimal-timing-for-laparoscopic-cholecystectomy-after-cholecystostomy-in-acute-cholecystitis-tokyo-iiiii-setting-100552666","NCT06476054","Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II\u002FIII Setting","Optimal Timing for Laparoscopic Cholecystectomy After Percutaneous Cholecystostomy in Acute Cholecystitis Tokyo II\u002FIII Setting: A Randomized Clinical Trial","Inclusion Criteria:\n\n* patients over 18 years of age\n* patients candidates for cholecystectomy, in scheduled surgery\n* patients who accept participation and sign informed consent form\n\nExclusion Criteria:\n\n* According to the principal investigator criteria, for reasons that make it impossible to correctly follow the treatment.\n* Presence of morbidity associated with the procedure that delays or makes treatment impossible.",{"count":83,"type":19},146,[22],"Percutaneous drainage in acute cholecystitis has been recommended by the recent update of the Tokyo Guidelines for patients with grade II and III disease who are unable to undergo surgical treatment due to their condition or associated comorbidities.\n\nThere are no reports providing high-quality scientific evidence on the optimal timing for surgery after percutaneous transhepatic gallbladder drainage, so a consensus has not been reached. The grade III stage generates the most controversy; after percutaneous drainage, delaying the cholecystectomy can lead to new episodes of exacerbation during the waiting period or may limit the procedure to a specific group of patients with this pathology.\n\nThe economic impact, including the number of readmissions, increased length of stay, and associated morbidity and mortality, generates controversy regarding the subsequent therapeutic decisions after the medical management of cholecystitis in this special group of patients.",[87],"Cholecystitis, Acute",[89,90,91,92],"Cholecystitis","Acute Cholecystitis","percutaneous drainage","laparoscopic cholecystectomy","2024-06-26",{"date":95,"type":36},"2024-06-28",{"date":97,"type":36},"2024-02-01",{"date":99,"type":19},"2027-08-01",{"name":42,"class":43},1,""]